- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clearpoint Neuro Inc (CLPT)
Clearpoint Neuro Inc stock price live, this page displays NASDAQ CLPT stock exchange data. View the CLPT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Clearpoint Neuro Inc real time stock price chart below.
What Is the Clearpoint Neuro Inc Stock Price Today?
The Clearpoint Neuro Inc stock price today is 10.67.
What Is the Stock Symbol for Clearpoint Neuro Inc?
The stock symbol for Clearpoint Neuro Inc is "CLPT."
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLPT quote. (ISIN: US18507C1036)
What Is the Clearpoint Neuro Inc Stock Price Today?
The Clearpoint Neuro Inc stock price today is 10.67.
What Is the Stock Symbol for Clearpoint Neuro Inc?
The stock symbol for Clearpoint Neuro Inc is "CLPT."
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLPT quote. (ISIN: US18507C1036)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.00
10.81
52 wk Range
8.27
19.68
CLPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.0010.81
52 wk Range
8.2719.68
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLPT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
21.50
Upside
+101.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to drop this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 21.50
(+101.50% Upside)
Clearpoint Neuro Inc Earnings Call Summary for Q3/2026
- Q3 revenue rose 36% YoY to $12.1M, slightly missing $12.27M consensus; record capital sales quarter despite gross margin decline to 58% from 63%.
- Operating expenses grew 23% YoY to $13.4M, slower than revenue growth, signaling improved leverage post-IRRAS acquisition integration.
- Management expects Q4 revenue to exceed Q3, targeting mid-teens base business growth in 2027 with formal guidance coming in early January.
- Key catalysts include FDA action on AMT-130 BLA within a month, multiple phase III trials in 12-15 months, and five IRRAflow milestones in 2027.
- Stock closed up 8.98% at $10.56 before slipping 1.61% after-hours; company remains unprofitable with $46.2M cash as of Sept. 30, 2026.
Last Updated: 10/29/2026, 05:34 AM
Read Full TranscriptEarnings
Latest Release
Oct 28, 2026
EPS / Forecast
-0.24 / -0.32
Revenue / Forecast
12.08M / 12.27M
Compare CLPT to Peers and Sector
Metrics to compare | CLPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.5x | −9.2x | −0.3x | |
PEG Ratio | 0.20 | −0.11 | 0.00 | |
Price/Book | 12.5x | 3.8x | 2.6x | |
Price / LTM Sales | 7.5x | 2.5x | 2.8x | |
Upside (Analyst Target) | 101.5% | 150.0% | 66.6% | |
Fair Value Upside | Unlock | 0.2% | 9.1% | Unlock |
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Clearpoint Neuro (CLPT) Stock Price Today?
The Clearpoint Neuro stock price today is 10.67 USD.
What Stock Exchange Does Clearpoint Neuro Trade On?
Clearpoint Neuro is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Clearpoint Neuro?
The stock symbol for Clearpoint Neuro is "CLPT."
What Is the Clearpoint Neuro Market Cap?
As of today, Clearpoint Neuro market cap is 342.66M USD.
What Is Clearpoint Neuro's Earnings Per Share (TTM)?
The Clearpoint Neuro EPS (TTM) is -1.21.
When Is the Next Clearpoint Neuro Earnings Date?
Clearpoint Neuro will release its next earnings report on Mar 03, 2027.
From a Technical Analysis Perspective, Is CLPT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Clearpoint Neuro Stock Split?
Clearpoint Neuro has split 1 times.
How Many Employees Does Clearpoint Neuro Have?
Clearpoint Neuro has 160 employees.
What is the current trading status of Clearpoint Neuro (CLPT)?
As of Oct 31, 2026, Clearpoint Neuro (CLPT) is trading at a price of 10.67 USD, with a previous close of 10.69 USD. The stock has fluctuated within a day range of 10.00 USD to 10.81 USD, while its 52-week range spans from 8.27 USD to 19.68 USD.
What Is Clearpoint Neuro (CLPT) Price Target According to Analysts?
The average 12-month price target for Clearpoint Neuro is 21.50 USD, with a high estimate of 25 USD and a low estimate of 18 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +101.50% Upside potential.
What Is the CLPT Premarket Price?
CLPT's last pre-market stock price is 10.80 USD. The pre-market share volume is 10,280.00, and the stock has decreased by 0.11, or 1.03%.
What Is the CLPT After Hours Price?
CLPT's last after hours stock price is 10.89 USD, the stock has decreased by 0.22, or 2.06%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.